| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |